Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.28% of ...

Compass Therapeutics Inc. (CMPX) stock saw a modest uptick, ending the day at $3.22 which represents a slight increase of $0.40 or 14.18% from the prior close of $2.82. The stock opened at $2.91 and ...